Extracellular interface between APP and Nicastrin regulates Aβ length and response to γ‐secretase modulators
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
c-Secretase complexes (GSECs) are multimeric membrane proteases involved in a variety of physiological processes and linked to Alzheimer's disease (AD).Presenilin (PSEN, catalytic subunit), Nicastrin (NCT), Presenilin Enhancer 2 (PEN-2), and Anterior Pharynx Defective 1 (APH1) are the essential subunits of GSECs.Mutations in PSEN and the Amyloid Precursor Protein (APP) cause early-onset AD.GSECs successively cut APP to generate amyloid-b (Ab) peptides of various lengths.AD-causing mutations destabilize GSEC-APP/Ab n interactions and thus enhance the production of longer Abs, which elicit neurotoxic events underlying pathogenesis.Here, we investigated the molecular strategies that anchor GSEC and APP/Ab n during the sequential proteolysis.Our studies reveal that a direct interaction between NCT ectodomain and APP C99 influences the stability of GSEC-Abn assemblies and thereby modulates Ab length.The data suggest a potential link between single-nucleotide variants in NCSTN and AD risk.Furthermore, our work indicates that an extracellular interface between the protease (NCT, PSEN) and the substrate (APP) represents the target for compounds (GSMs) modulating Ab length.Our findings may guide future rationale-based drug discovery efforts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818 · cited 1×
“PSEN bears the catalytic center of the enzyme (De Strooper et al , 1998; Steiner et al , 1999; Wolfe et al , 1999; Ahn et al , 2010), while the other “non-catalytic” subunits of the protease are required for the complex assembly, activation, structural stability/turnover, and trafficking…”
Aph-1, Pen-2, and Nicastrin with Presenilin Generate an Active γ-Secretase Complex
De Strooper, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00205-8 · Cited by 965 · cited 1×
“…has been assembled, PSEN undergoes auto-endoproteo-lytic cleavage, which yields an active pentameric protease complex, with the catalytic center located at the interface between the N-and C-terminal fragments (NTF vs. CTF) of PSEN (De Strooper, 2003; Edbauer et al , 2003; Selkoe & Wolfe, 2007).”
Molecular genetics of early-onset Alzheimer’s disease revisited
Cacace, R., Sleegers, K., & Van Broeckhoven, C. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.01.012 · Cited by 617 · cited 1×
“…PSEN2 and APP are thought to account for only 5-10% of all early-onset AD (EOAD, onset 65 y) cases, while the heritability of EOAD has been estimated to range from 92 to 100%, thus leaving 90 – 95% of the affected families with an unidentified genetic cause for the disease (Cacace et al , 2016).”
Takami, M., Nagashima, Y., Sano, Y., Ishihara, S., Morishima-Kawashima, M., Funamoto, S., & Ihara, Y. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2362-09.2009 · Cited by 498
The mechanism of γ‐Secretase dysfunction in familial Alzheimer disease
Chávez‐Gutiérrez, L., Bammens, L., Benilova, I., Vandersteen, A., Benurwar, M., Borgers, M., Lismont, S., Zhou, L., Van Cleynenbreugel, S., Esselmann, H., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.79 · Cited by 495 · cited 1×
“Importantly, disease-causing mutations in PSEN1 and PSEN2 genes consistently impair the efficiency of the c -cleavages, shifting A b profiles toward the generation of longer amyloidogenic peptides (Cha´vez-Gutie´rrez et al , 2012; Fernandez et al , 2014; Moore et al , 2015; Veugelen et al , 2016).”
Self-citationThe amyloid cascade hypothesis: are we poised for success or failure?
Karran, E., & De Strooper, B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13632 · Cited by 402 · cited 1×
“This so-called “GSEC dysfunction” promotes — as demonstrated by the analysis of post-mortem brain samples from FAD patients (Szaruga et al , 2015) — the production of longer A b ≥ 42 peptides, which trigger neurotoxic events underlying AD (Karran & De Strooper, 2016; Selkoe & Hardy, 2016).”
Qi-Takahara, Y., Morishima-Kawashima, M., Tanimura, Y., Dolios, G., Hirotani, N., Horikoshi, Y., Kametani, F., Maeda, M., Saido, T. C., Wang, R., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1575-04.2005 · Cited by 391 · cited 8×
“APP C99 is the most studied substrate of GSECs due to its genetic and biochemical link to AD pathogenesis.”
InfluentialRecognition of the amyloid precursor protein by human γ-secretase
Zhou, R., Yang, G., Guo, X., Zhou, Q., Lei, J., & Shi, Y. (2019) · Science · doi:10.1126/science.aaw0930 · Cited by 304
Alzheimer’s-Causing Mutations Shift Aβ Length by Destabilizing γ-Secretase-Aβn Interactions
Szaruga, M., Munteanu, B., Lismont, S., Veugelen, S., Horré, K., Mercken, M., Saido, T. C., Ryan, N. S., De Vos, T., Savvides, S. N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.004 · Cited by 248 · cited 9×
“Of note, a remarkable correlation between the magnitude of the mutant-induced weakening of the stability of the E-S complexes and the corresponding age of disease onset (Szaruga et al , 2017) places the generation of longer A b ≥ 42 peptides central to AD pathogenesis.”
InfluentialSelf-citationQualitative changes in human γ-secretase underlie familial Alzheimer’s disease
Szaruga, M., Veugelen, S., Benurwar, M., Lismont, S., Sepulveda-Falla, D., Lleo, A., Ryan, N. S., Lashley, T., Fox, N. C., Murayama, S., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150892 · Cited by 155 · cited 2×
“This so-called “GSEC dysfunction” promotes — as demonstrated by the analysis of post-mortem brain samples from FAD patients (Szaruga et al , 2015) — the production of longer A b ≥ 42 peptides, which trigger neurotoxic events underlying AD (Karran & De Strooper, 2016; Selkoe & Hardy, 2016).”
Self-citation
Cited by
Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2
Lichtenthaler, S. F., Tschirner, S. K., & Steiner, H. (2022) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2021.09.003 · Cited by 60
Gardenia jasminoides J.Ellis extract GJ-4 alleviated cognitive deficits of APP/PS1 transgenic mice
Zang, C., Liu, H., Shang, J., Yang, H., Wang, L., Sheng, C., Zhang, Z., Bao, X., Yu, Y., Yao, X., et al. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153780 · Cited by 22
Arber, C., Villegas-Llerena, C., Toombs, J., Pocock, J. M., Ryan, N. S., Fox, N. C., Zetterberg, H., Hardy, J., & Wray, S. (2019) · Brain Communications · doi:10.1093/braincomms/fcz024 · Cited by 19
“, 2019) and mechanistic studies (Szaruga et al., 2017; Petit et al., 2019) whereby fAD mutations appear to destabilize substrate to holo-enzyme complex interaction to release longer Ab fragments before complete enzymatic processing, rather than altering the PSEN1 subunit activity.”
BackgroundSelf-citationOdorčić, I., Hamed, M. B., Lismont, S., Chávez-Gutiérrez, L., & Efremov, R. G. (2024) · Nature Communications · doi:10.1038/s41467-024-48776-2 · Cited by 15
Self-citation
Metadata
- Authors
- Petit, D., Hitzenberger, M., Lismont, S., Zoltowska, K. M., Ryan, N. S., Mercken, M., Bischoff, F., Zacharias, M., & Chávez‐Gutiérrez, L.
- Venue
- The EMBO Journal
- Published
- 2019-05-20
- Volume
- 38
- Issue
- 12
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- OpenAlex
- W2946826056
- Cited by
- 50
- References
- 12
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.